Cancers·Non-Hodgkin lymphoma (all types)

Where you areNon-Hodgkin lymphoma (all types)

Back to the Non-Hodgkin lymphoma hub →

Cases by country, the UK and NHS pathway and other country lenses, and the expert centres with trials on record.

Where you are

top

Every country →Coverage by country →

Cases by country

Cases by country · GLOBOCAN 2022

All countries →

No country-level case numbers. This cancer is not mapped to a GLOBOCAN site.

Expert centres

Where the expertise is

Expert centres

7 centres in 7 countries · 0 with a trial for this cancer on record · second-opinion finder →

Choose a region from the globe in the header to mark centres near you.

7 centres


BC Cancer Vancouver, BC · cancer center	Canada	none recorded	305	2,733	Whole-exome & whole-genome sequencing RNA sequencing & expression profiling Single-cell & spatial profiling HPV DNA testing and self-sampling +2	-
Walter and Eliza Hall Institute of Medical Research Melbourne · research institute	Australia	none recorded	298	3,639	CRISPR functional genomics Patient-derived organoids	-
IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico Sant'Orsola Bologna · hospital	Italy	none recorded	229	2,386	CAR-T cell therapy Bispecific antibodies Allogeneic (off-the-shelf) cell therapy	-
HOVON Rotterdam · consortium	Netherlands	none recorded	8	207	MRD / molecular residual disease testing	-
German Hodgkin Study Group Cologne · consortium	Germany	none recorded	not matched	-	FDG PET Antibody-drug conjugate (ADC)Cytotoxic chemotherapy	-
LYSA (The Lymphoma Study Association) Pierre-Bénite (Lyon) · consortium	France	none recorded	not matched	-	Monoclonal antibodies Bispecific antibodies CAR-T cell therapy FDG PET	-
The Ohio State University Comprehensive Cancer Center, James Cancer Hospital and Solove Research Institute Columbus, OH · cancer center	United States	NCI comprehensive	not matched	-	Small-molecule kinase inhibitors Proton therapy Proton therapy machines: cyclotrons, synchrotrons and single-room systems	-

These are the things we can measure; they are not a ranking of quality. Each column is a field on the institution record or a count over what OnCo has linked; a centre that treats many patients with Non-Hodgkin lymphoma but is thinly recorded here will look small.

Not known: OnCo holds no case-volume or outcome figures for centres, so none are shown. Where a national audit or registry publishes them, the centre's page links to it. Default order: Newsweek rank, then trials for this cancer, then research output.

Seeking a second opinion: ask your oncologist for a referral to a high-volume centre; most accept records and pathology by mail or telehealth. In the US, use the NCI's Find a Cancer Center tool or the nonprofit Cancer Commons, which navigates options for advanced cancers at no cost. The second-opinion finder explains how referral works in your country.

Cancers·Non-Hodgkin lymphoma (all types)

Where you areNon-Hodgkin lymphoma (all types)

Back to the Non-Hodgkin lymphoma hub →

Cases by country, the UK and NHS pathway and other country lenses, and the expert centres with trials on record.

Where you are

top

Every country →Coverage by country →

Cases by country

Cases by country · GLOBOCAN 2022

All countries →

No country-level case numbers. This cancer is not mapped to a GLOBOCAN site.

Expert centres

Where the expertise is

Expert centres

7 centres in 7 countries · 0 with a trial for this cancer on record · second-opinion finder →

Choose a region from the globe in the header to mark centres near you.

7 centres


BC Cancer Vancouver, BC · cancer center	Canada	none recorded	305	2,733	Whole-exome & whole-genome sequencing RNA sequencing & expression profiling Single-cell & spatial profiling HPV DNA testing and self-sampling +2	-
Walter and Eliza Hall Institute of Medical Research Melbourne · research institute	Australia	none recorded	298	3,639	CRISPR functional genomics Patient-derived organoids	-
IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico Sant'Orsola Bologna · hospital	Italy	none recorded	229	2,386	CAR-T cell therapy Bispecific antibodies Allogeneic (off-the-shelf) cell therapy	-
HOVON Rotterdam · consortium	Netherlands	none recorded	8	207	MRD / molecular residual disease testing	-
German Hodgkin Study Group Cologne · consortium	Germany	none recorded	not matched	-	FDG PET Antibody-drug conjugate (ADC)Cytotoxic chemotherapy	-
LYSA (The Lymphoma Study Association) Pierre-Bénite (Lyon) · consortium	France	none recorded	not matched	-	Monoclonal antibodies Bispecific antibodies CAR-T cell therapy FDG PET	-
The Ohio State University Comprehensive Cancer Center, James Cancer Hospital and Solove Research Institute Columbus, OH · cancer center	United States	NCI comprehensive	not matched	-	Small-molecule kinase inhibitors Proton therapy Proton therapy machines: cyclotrons, synchrotrons and single-room systems	-

These are the things we can measure; they are not a ranking of quality. Each column is a field on the institution record or a count over what OnCo has linked; a centre that treats many patients with Non-Hodgkin lymphoma but is thinly recorded here will look small.

Not known: OnCo holds no case-volume or outcome figures for centres, so none are shown. Where a national audit or registry publishes them, the centre's page links to it. Default order: Newsweek rank, then trials for this cancer, then research output.

Seeking a second opinion: ask your oncologist for a referral to a high-volume centre; most accept records and pathology by mail or telehealth. In the US, use the NCI's Find a Cancer Center tool or the nonprofit Cancer Commons, which navigates options for advanced cancers at no cost. The second-opinion finder explains how referral works in your country.